No photo available.

Giampaolo Talamo, M.D.

Associate Professor of Medicine

Office Information

Penn State Cancer Institute
500 University Drive, CH46
Hershey, PA 17033
Tel: 800-243-1455 / 717-531-6585 Fax: 717-531-0429



Patient Services Provided

Multiple Myeloma Plasma Cell Leukemia Primary Amyloidosis Stem Cell Transplantation

Practice Locations

Biographical Information

During his career, Dr. Talamo had the privilege of working with famous oncologists, such as Dr. James F. Holland in New York City, and Dr. Bart Barlogie at the Myeloma Institute for Research and Therapy at the University of Arkansas. Dr. Talamo has extensive experience in high-dose chemotherapy and autologous/allogeneic stem cell transplantation. He came to Hershey in 2007, and he devotes his clinical activity mainly to the treatment of multiple myeloma and other plasma cell disorders, such as plasma cell leukemia, primary amyloidosis, light chain deposition disease, and monoclonal gammopathy of undetermined significance (MGUS). More information is available at his personal web site ( [N.B.: external link, unrelated to Penn State Cancer Institute and unrelated to Penn State Health Milton S. Hershey Medical Center].

Professional Education

Fellowship, Hematology/Oncology, Mount Sinai School of Medicine of NY University (1998) Residency, Internal Medicine, Cabrini Medical Center - New York (1996) M.D., Universita' Degli Studi Di Perugia - Italy (1989)


Talamo G, Claxton DF, Dougherty DW, et al.
BU and CY as conditioning regimen for autologous transplant in patients with multiple myeloma
Bone Marrow Transplantation, 2009 Aug; 44(3):157-61
Talamo G, Cavallo F, Zangari M, et al
Hyperammonemia and encephalopathy in patients with multiple myeloma
American Journal of Hematology, 2007; 82:414-5
Talamo G, Cavallo F, Zangari M, et al
Clinical and biological features of multiple myeloma involving the gastrointestinal system
Haematologica, 2006; 91:964-7
Talamo G, Angtuaco E, Walker RC, et al
Avascular necrosis of femoral and/or humeral heads in multiple myeloma: results of a prospective study of patients treated with dexamethasone-based regimens and high-dose chemotherapy
Journal of Clinical Oncology, 2005 Aug 1; 23(22):5217-23
Grignani F, Ferrucci PF, Testa U, Talamo G, et al
The Acute Promyelocytic Leukemia-specific PML-RARalpha fusion protein inhibits differentiation and promotes survival of myeloid precursor cells
Cell, Aug 1993, Vol. 74, p. 423-31